Millennium Management’s Aerie Pharmaceuticals AERI Stock Holding History

Millennium Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$192K	–	4765
2019 Q3	$192K	Hold	10,000	–	–	﹤0.01%	3806
2019 Q2	$296K	Buy	+10,000	New	+$385K	﹤0.01%	3551
2018 Q4	–	Sell	-99,700	Closed	-$6.14M	–	4330
2018 Q3	$6.14M	Buy	+99,700	New	+$6.41M	0.01%	1653
2018 Q1	–	Sell	-53,700	Closed	-$3.21M	–	4209
2017 Q4	$3.21M	Sell	53,700 -86,300	-62%	-$5.23M	﹤0.01%	1987
2017 Q3	$6.8M	Buy	+140,000	New	+$7.64M	0.01%	1490
2015 Q4	–	Sell	-1,000,000	Closed	-$17.7M	–	3872
2015 Q3	$17.7M	Buy	+1,000,000	New	+$18.1M	0.03%	622
2015 Q2	–	Sell	-200,000	Closed	-$6.27M	–	3986
2015 Q1	$6.27M	Buy	+200,000	New	+$5.8M	0.01%	1289

Millennium Management's AERI Position: Q4 2022 in Review

Millennium Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 118,240 shares — an estimated $1.79M sold.

Millennium Management first reported a position in AERI in Q4 2013 and held it in 31 quarters. The position peaked at $49.3M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

Millennium Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 118,240 Aerie Pharmaceuticals shares in Q4 2022, an estimated $1.79M.
Millennium Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 31 quarters.
Millennium Management's Aerie Pharmaceuticals position peaked at $49.3M in Q1 2017.
0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.